Cannabis Law Report

DECEMBER 23, 2021

DUBLIN–(BUSINESS WIRE)– “The Pharmaceutical Cannabis Report: 2nd Edition” report has been added to ResearchAndMarkets.com’s offering. This report has been compiled to assist interested parties in understanding the market for the medical use of cannabinoids and where it may be heading.

Pharmaceutical 96

Pharmaceutical Clinical Trials Research and Development Cannabinoids 96

Cannabis Law Report

JULY 12, 2019

International Cannabinoid Cancer Research Institute (Draft 5). However, there are indications from studies done with cannabidiol-rich cannabis extracts in Israel that indicate that less side effects (46%) are achieved with a natural cannabis plant extract containing a 20:1 ratio of CBD to THC. Research Director.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

FEBRUARY 23, 2022

(TSX: LABS) (OTCQX: MEDIF ) (FSE: MLZ) (“MediPharm” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it has completed a US FDA DMF for pure natural CBD API. These projects will all require pharmaceutical approved API if commercialized. Management Commentary.

Pharmaceutical 52

Pharmaceutical Research and Development Extraction Cannabinoids 52

Cannabis Law Report

NOVEMBER 22, 2019

Nextleaf Solutions Ltd ( CSE:OILS ) (OTCMKTS:OILFF) has been awarded two patents related to extraction of THC and CBD, bringing its total issued patents to ten. Nextleaf’s technology enables lower-quality dried cannabis and hemp biomass to be processed at scale into high-purity THC and CBD distilled oil. ” . ”

Extraction 59

Extraction Cannabinoids Oil Pharmaceutical 59

Cannabis Law Report

FEBRUARY 18, 2022

We are one of the first to successfully complete a commercial shipment of Colombian-manufactured high-CBD pharmaceutical product to Germany available for patients in pharmacies under prescription. In addition, this reflects our increasing know-how to comply with complex and sophisticated regulatory and quality frameworks.

Extraction 52

Extraction Pharmaceutical Patients Cannabinoids 52

Cannabis Law Report

MAY 29, 2021

The authorization procedure for the extraction of active ingredients and the production of cannabis extracts was published by the Ministry of Health after an explicit request from the M5S.

Extraction 78

Extraction Agriculture Cultivation Pharmaceutical 78

Project CBD

JULY 28, 2023

Scialdone is a founding member of the Cannabis Chemistry Subdivision of the American Chemical Society from which he received the 2018 CANN-CHAS Heidolph Award for Excellence in Cannabis Chemistry. These are not present in cannabis and are only formed in the chemical conversion, whose impact on human health is unknown.

THC 212

THC Cannabinoids Hemp Research and Development 212

Project CBD

NOVEMBER 11, 2023

NM: As someone who has been researching cannabis for decades, how do you feel about the current legalization situation worldwide and in Japan, in particular? Dr. Andrew Weil: I think the trend very clearly is that in most developed countries, cannabis is being made legal first for medical uses and then also for recreational uses.

Medicine 301

Medicine Research and Development Pharmaceutical Cannabis 301

Kind Meds (Cannabis Education Blog)

JANUARY 27, 2022

Since the popularization of CBD in recent years, it’s more common to see cannabis recognized as a true medical treatment. However, CBD and the psychoactive THC aren’t the only compounds found in the cannabis plant. Lately, the cannabinoid CBN (or cannabinol) has been rising in popularity. What Is CBN Extraction?

Cannabinoids 52

Cannabinoids Treatment Extraction THC 52

Cannabis Law Report

AUGUST 9, 2021

Cannassure Therapeutics Ltd (TASE: CSURE) (“Cannassure”), an Israel based developer and producer of innovative medical cannabis products, announces today that the company was granted a patent for an oral delivery method of cannabis and cannabinoids compositions by the Israel Patents Authority.

Cannabinoids 98

Cannabinoids Pharmaceutical Treatment Patients 98

Cannabis Law Report

JANUARY 16, 2020

(“Devonian” or the “Corporation”) (TSXv:GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announced today the signature of a lease Agreement with Hzb Pharma Canada Inc. Tweet this.

Extraction 64

Extraction Pharmaceutical Research and Development Terpenes 64

Cannabis Law Report

NOVEMBER 12, 2021

Kyle Detwiler, CEO of Clever Leaves, and Andrés Fajardo, President of Clever Leaves, met with Ruud Helwig, Managing Director Ethypharm Germany, for a strategy meeting in Berlin to coordinate the approach and marketing strategies for the upcoming medical cannabis market entry in early 2022.

Extraction 52

Extraction Chronic Pain Pharmaceutical THC 52

Cannabis Law Report

SEPTEMBER 17, 2021

Patent 16/424,351, a Cannabinoid Composition and Method of Sublingual, Buccal, and Oral Mucosa Delivery. This patent focuses on a formulation that includes a cannabinoid extract that is pharmaceutically effective by systemic delivery to the recipient’s oral mucosal lining. Lassen Labs a subsidiary of InBOLD Inc.

Cannabinoids 52

Cannabinoids Pharmaceutical Digestion Terpenes 52

Veriheal

AUGUST 9, 2023

Recent research reaffirms earlier studies that claim that certain non-marijuana plants contain similar compounds found in cannabis, often called cannabinoids. Presently, CBD is inarguably the most acceptable compound in cannabis.

CBD 93

CBD Cannabinoids THC Extraction 93

The Cannigma

FEBRUARY 1, 2023

Patients are often left to their own devices when looking into cannabis and cancer, given the lack of clinical evidence, and stigma surrounding the use of the plant as medicine. Individuals who use cannabis-based medications often want to cure their cancer, not just reduce the symptoms that come with the condition. The answer: Maybe!

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

Canna Care Docs

OCTOBER 3, 2023

However, many of these pharmaceutical medications can just induce more unpleasant, debilitating effects on those who are ill. Natural plant therapy , and cannabis specifically, has been studied for its effectiveness in alleviating and treating many of these physiological and emotional symptoms that come into play with a terminal illness.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

Cannabis Law Report

JANUARY 11, 2022

Flora’s cultivation and extraction division, Cosechemos, completed construction of a 10,500 ft 2 state-of-the-art post-harvest and extraction facility with annual capacity of 15,000 L of distillate. At this time, the team is continuing commercial CBD extraction. MIAMI & TORONTO–(BUSINESS WIRE)–Flora Growth Corp.

Extraction 52

Extraction Wellness and Beauty Events Cultivation 52

Cannabis Law Report

JUNE 1, 2022

(TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a global leader in medical cannabis throughout Europe and Latin America, announces that it has entered into an agreement to acquire Pharmadrug GmbH from its parent PharmaDrug Inc. CSE:PHRX) (OTC:LMLLF). This will have a direct positive impact on our revenues and higher gross margins.

Pharmaceutical 52

Pharmaceutical Medicine Extraction Cannabinoids 52

SpeedWeed

MAY 10, 2021

If you or a loved one suffer from depression, rare cannabinoid CBC (cannabichromene) may offer hope for a happier future. The third most prevalent cannabinoid in hemp and cannabis, CBC’s mood-elevating properties are about ten times more effective than CBD, making it a promising cannabinoid for reducing stress.

Cannabinoids 52

Cannabinoids Terpenes Tincture Oil 52

CannaTech

NOVEMBER 6, 2019

In today’s blog, we are joined by Matthew Anderson, Founder/CEO Vanguard Scientific Systems, a world-leading provider of end-to-end solutions for integrated botanical extraction equipment and services. The Cannabinoid Buyer’s Needs of Tomorrow. But is this growth serving the needs of cannabinoid buyers?

Cannabinoids 74

Cannabinoids Wellness and Beauty Supply Chain Compliance 74

Cannabis Law Report

JANUARY 13, 2020

Hemp Synergistics, a hemp extraction laboratory producing THC-free custom CBD formulations recently announced it received $1.5 The lab has been designed to resolve the problem of inconsistent THC levels in a range of cannabinoid-based consumer products, the company told Benzinga.

Extraction 66

Extraction Hemp Environment Pharmaceutical 66

Project CBD

AUGUST 23, 2023

Earlier this year, the Food & Drug Administration disclosed that it would not regulate non-pharmaceutical CBD products, thereby putting the onus on Congress to devise an appropriate regulatory framework for cannabidiol and other hemp-derived cannabinoids. 5 The so-called “hemp” market is no longer predominantly a wellness market.

Cannabinoids 141

Cannabinoids Hemp THC Safety 141

United Patients Group

FEBRUARY 7, 2023

Benefits of Cannabis for Inflammation and Pain Introduction Inflammation and pain are two of the most common health issues that many people face. Cannabis has been used as medicine for thousands of years, and there are many different ways this plant can help with inflammation and pain relief by interacting with our bodies in different ways.

Cannabinoids 115

Cannabinoids Chronic Pain Terpenes THC 115

Cannabis Law Report

SEPTEMBER 14, 2021

A lack of consumer trust, transparency and scientific rigor has hampered the CBD and cannabinoid industry from reaching its growth potential for far too long”. To learn more about the Radicle Science-OBX alliance, read The Movement Is On! About Radicle Science.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Otherside Farms

MAY 1, 2023

If you’re in the cannabis industry, you’re likely no stranger to the latest trends and technologies. As the cannabis industry continues to grow, the need for high-quality extraction methods becomes more important than ever. What exactly is CO2 Extraction? What exactly is CO2 Extraction?

Extraction 52

Extraction Terpenes Oil Cannabinoids 52

Cannabis Law Report

NOVEMBER 23, 2021

SOMAÍ Pharmaceuticals Unipessoal LDA, or SOMAÍ, recently received an “innovative products” grant of 2.7 Provided by the Portugal 2020 committee, the grant will help Somaí continue its mission of developing high-quality and efficacious cannabis pharmaceuticals for the European market. million euros ($3.07

Pharmaceutical 52

Pharmaceutical Research and Development Cannabinoids Extraction 52

Project CBD

MAY 3, 2023

This transcript is adapted from CannMed’s weekly podcast , hosted by Ben Amirault, who recently interviewed Bonni Goldstein, MD, one of the country’s most respected and experienced medical cannabis physicians. Dr. Goldstein has treated thousands of patients with medical cannabis. CBG is not intoxicating or impairing.

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

Green Relief

MARCH 25, 2018

Cannabidiol (CBD) has been the focus of many medical cannabis studies, and continues to prove itself as a powerful anti-inflammatory drug. The study examines the effectiveness of administering isolated cannabinoid extracts (a CBD-only formula) versus whole plant extracts (which contain the full range of the plant’s cannabinoid content).

Extraction 41

Extraction CBD Cannabinoids Strains 41

Cannabis Law Report

OCTOBER 26, 2019

Here’s Cannabis Wire’s introduction to their investigation. The US subsidiary of GW Pharmaceuticals, behind the only FDA-approved cannabis extract-based medicine, is lobbying in all 50 states. Read the full story on Cannabis Wire. . The Incredibly Large Lobbying Footprint of Greenwich Biosciences.

Pharmaceutical 45

Pharmaceutical Research and Development Banking Therapy 45

Cannabis Law Report

SEPTEMBER 17, 2022

Shipment made to an established pharmaceutical distributor and clinical research organization in the Czech Republic , focused on medicinal grade cannabinoids. The customer is an established cannabinoid-focused pharmaceutical distributor and clinical research organization in the country. Thu, September 15, 2022 .

Medicine 52

Medicine Research and Development Pharmaceutical Cannabinoids 52

Cannabis Law Report

DECEMBER 1, 2021

Cannabis and Life Sciences Company Initiates Internal Study Comparing Anti-Inflammatory Properties of Candidate JUVA-019 When Combined With Cannabinoids Such as THC and CBD. who has an extensive background in pharmaceutical research and development. November 30, 2021 04:00 ET | Source: Juva Life Inc.

Cannabinoids 52

Cannabinoids Research and Development Pharmaceutical THC 52

Cannabis Law Report

JULY 27, 2021

The initiative is part of Project Change Lives; Clever Leaves’ $25M product pledge to aid cannabis research in the U.S. today announced a joint partnership with the intent to study the DNA sequence variation of three Clever Leaves’ cannabis cultivars as part of their Project Change Lives campaign.

Research and Development 98

Research and Development Pharmaceutical Sativa Extraction 98

Cannabis Law Report

NOVEMBER 17, 2021

Launch of Zylem ™ 20:1 further expands ZYUS product offerings with new cannabinoid formulation. The launch of this formulation marks an important milestone in ZYUS’ mission to elevate cannabinoids as a standard of care and leverage their transformational potential.

Cannabinoids 52

Cannabinoids Patients Research and Development Extraction 52

Cannabis Law Report

SEPTEMBER 7, 2022

The acquisition by Ramm provides access to HemPoland’s distribution network, recognized premium brands, hemp oil extraction technologies, and an additional synergistic foothold into the European market following the acquisition of Sicily-based Canapar Corp. About RAMM Pharma Corp. g, Poland (60 kilometres east of Gda?sk), HemPoland S.p.a.

Hemp 59

Hemp Pharmaceutical Extraction Cannabinoids 59

Cannabis Law Report

MAY 30, 2019

(CSE: BBT) (FSE: BBW) (OTC Pink: BHHKF) (“Benchmark”, “BBT” or the “Company”) a federally-licensed producer and distributor of medical-grade cannabis, is pleased to report that it has signed a definitive agreement with China-based Zhejiang Yatai Pharmaceutical Co.,

Pharmaceutical 40

Pharmaceutical Research and Development Extraction Cultivation 40

SpeedWeed

JULY 16, 2021

THCV is a cannabinoid found in cannabis, hemp, and other plants, but it naturally forms in such small quantities that, until very recently, it had an almost mythical status. Cannabis strains high in THCV were found in equatorial Africa, where locals used them as stimulants and to stave off hunger. THCV is a cannabinoid.

Cannabinoids 52

Cannabinoids Oil THC CBD 52

Cannabis Law Report

JANUARY 16, 2022

The government will review the Dangerous Drugs Act 1952 and the Poisons Act 1952 to regulate cannabis and ketum for medical use, Health Minister Khairy Jamaluddin said. Cannabis, or marijuana, is currently banned under the Dangerous Drugs Act that imposes extremely harsh penalties for the use of illegal narcotics.

Research and Development 98

Research and Development Pharmaceutical Epilepsy Medicine 98